Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Salim Yusuf"'
Publikováno v:
New England Journal of Medicine. 388:1621-1623
Autor:
Stuart J, Connolly, Ganesan, Karthikeyan, Mpiko, Ntsekhe, Abraham, Haileamlak, Ahmed, El Sayed, Alaa, El Ghamrawy, Albertino, Damasceno, Alvaro, Avezum, Antonio M L, Dans, Bernard, Gitura, Dayi, Hu, Emmanuel R, Kamanzi, Fathi, Maklady, Golden, Fana, J Antonio, Gonzalez-Hermosillo, John, Musuku, Khawar, Kazmi, Liesl, Zühlke, Lillian, Gondwe, Changsheng, Ma, Maria, Paniagua, Okechukwu S, Ogah, Onkabetse J, Molefe-Baikai, Peter, Lwabi, Pilly, Chillo, Sanjib K, Sharma, Tantchou T J, Cabral, Wadea M, Tarhuni, Alexander, Benz, Martin, van Eikels, Amy, Krol, Divya, Pattath, Kumar, Balasubramanian, Sumathy, Rangarajan, Chinthanie, Ramasundarahettige, Bongani, Mayosi, Salim, Yusuf, T, Mpofu
Publikováno v:
New England Journal of Medicine. 387:978-988
Testing of factor Xa inhibitors for the prevention of cardiovascular events in patients with rheumatic heart disease-associated atrial fibrillation has been limited.We enrolled patients with atrial fibrillation and echocardiographically documented rh
Publikováno v:
New England Journal of Medicine. 385:378-380
Autor:
Stephane Ederhy, Gilmar Reis, Andrzej Rynkiewicz, Keith Fox, Luca Padua, Helene ABERGEL, Andrew Murphy, Andrzej Szuba, YAN CARLOS DUARTE VERA, Pawel Maga, Scott Berkowitz, Roxana Buzas, Alexey Repin, Gregory Ducrocq, Olga Barbarash, Anton Sadomov, Grzegorz Gajos, Miguel Urina, David McEneaney, Richard Tytus, Dmitriy Panov, Angelika Chachaj, Weimar Kunz Sebba Barroso Souza, Akihiko Takahashi, Salim Yusuf, Mpiko Ntsekhe, Elena Gromova, David Halon, Richard Cheng, Marcello Galvani, Rohan Poulter, JUAN PABLO YEPEZ ALVARAN, Sara Doimo, Kim Houlind, Marcelo Arruda Nakazone, Avinainder Singh, Fabrice Martens, Aldo Pietro Maggioni, Fredrik Folke, Miroslav Brtko, Peter Verhamme, Laszlo Koranyi, Bart Meuris, ALVARO AVEZUM, Boris Vesga, Cyrille Boulogne, Peter Sinnaeve, Zhanna Sizova, Marianna Janion, Crina Julieta Sinescu, Laurent BERTOLETTI, Susanne Brenner, Jaroslav Hlubocký, ELENA BOBESCU, Michelle Canavan, Kamil Bury, Elena Nalesnik, Robert Mikulik, Yaroslav Malynovsky, Liudmyla Parkhomenko, Andrea Barbieri, Philippe Gabriel STEG, Kelley Branch, Olga Shestakovska, Jan Fedacko, Khairul Shafiq Ibrahim, Nicolae-Dan Tesloianu, Daniel Pella, Paul Fedak, Pavel Kaplan, Shirley Jansen, Martin O'Donnell, Marlena Broncel, Fernando Lanas, Stefan Störk, Natalia Garganeeva, Heyman Luckraz, CARLOS AUGUSTO CELEMIN FLOREZ, Larysa Mishchenko, Amos Katz, Jaroslava Paulasova Schwabova, Patricio Lopez-Jaramillo, Gustavo Aroca, Monika Możdżan, Zoltan Varallyay, María José Paucar, Tim Ramsay, Fernando Botto, Muhammad Imran Abdul Hafidz, Juan Esteban Gómez-Mesa, Kaijian Hou, Miroslav Spacek, Tomasz Guzik, Diego Rizzotti, Jackie Bosch, Shrikant Bangdiwala, Robert Welsh, Vojtěch Novotný, Andriy Bazylevych, Niall Mahon, Serhii Serik, Irina PARVU, Daniel Turek, Laurent Feldman, Dmitry Zateyshchikov, Mykola Bychkov, Yury Vasyuk, Camilo Felix, James Cotton, DHAYRA KAREM BARRETO, Sergey Kozhukhov, Sergio Zimmermann, Whady Hueb
Publikováno v:
Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S & COMPASS Investigators 2017, ' Rivaroxaban with or without aspirin in stable cardiovascular disease ', New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (14), pp.1319-1330. ⟨10.1056/NEJMoa1709118⟩
Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A K, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S, COMPASS Investigators & Houlind, K C 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England journal of medicine, 377(14), 1319-1330. Massachussetts Medical Society
COMPASS Investigators 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (14), pp.1319-1330. ⟨10.1056/NEJMoa1709118⟩
Eikelboom, J W, Connolly, S J, Bosch, J, Dagenais, G R, Hart, R G, Shestakovska, O, Diaz, R, Alings, M, Lonn, E M, Anand, S S, Widimsky, P, Hori, M, Avezum, A, Piegas, L S, Branch, K R H, Probstfield, J, Bhatt, D L, Zhu, J, Liang, Y, Maggioni, A P, Lopez-Jaramillo, P, O'Donnell, M, Kakkar, A K, Fox, K A A, Parkhomenko, A N, Ertl, G, Störk, S, Keltai, M, Ryden, L, Pogosova, N, Dans, A L, Lanas, F, Commerford, P J, Torp-Pedersen, C, Guzik, T J, Verhamme, P B, Vinereanu, D, Kim, J-H, Tonkin, A M, Lewis, B S, Felix, C, Yusoff, K, Steg, P G, Metsarinne, K P, Cook Bruns, N, Misselwitz, F, Chen, E, Leong, D, Yusuf, S, COMPASS Investigators & Houlind, K C 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
New England journal of medicine, 377(14), 1319-1330. Massachussetts Medical Society
COMPASS Investigators 2017, ' Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease ', The New England Journal of Medicine, vol. 377, no. 14, pp. 1319-1330 . https://doi.org/10.1056/NEJMoa1709118
BACKGROUND: We evaluated whether rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone for secondary cardiovascular prevention.METHODS: In this double-blind trial, we randomly assigned 27,395 participants with st
Autor:
Oliver Bernecker, Heather Iles-Smith, Umberto Benedetto, Salim Yusuf, Marek Cisowski, John Henry Dark, Stephen Clark, Andrzej Bochenek, Alastair Gray, Marek Jasinski, Dipak Kotecha, Guglielmo Mario Actis Dato, Kazimierz Widenka, Graham Cooper, Stephen Gerry, Vipin Zamvar
Publikováno v:
Taggart, D, Altman, D, Gray, A, Lees, B, Gerry, S, Benedetto, U & Flather, M 2016, ' Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts ', New England Journal of Medicine, vol. 375, no. 26, pp. 2540-2549 . https://doi.org/10.1056/NEJMoa1610021
BackgroundThe use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-term outcomes as compared with the use of a single internal-thoracic-artery plus vein grafts.MethodsWe randomly assigned p
Autor:
Balram Airan, Fernando Lanas Zanetti, Chandrasekar Padmanabhan, Ahmet Rüçhan Akar, Liang Tao, Yongning Ou, Leopoldo S. Piegas, Toomas-Andres Sulling, Andre Lamy, Shengshou Hu, Richard P. Whitlock, Philip J. Devereaux, Alvaro Avezum, Zbynek Straka, Nicolas Noiseux, Anil Jain, Pablo A. Olavegogeascoechea, Richard J. Novick, Juan-Carlos Bahamondes, David P. Taggart, Peggy Gao, Salim Yusuf, Shirley Pettit, Dorairaj Prabhakaran
Publikováno v:
New England Journal of Medicine. 375:2359-2368
BackgroundWe previously reported that there was no significant difference at 30 days or at 1 year in the rate of the composite outcome of death, stroke, myocardial infarction, or renal failure between patients who underwent coronary-artery bypass gra
Autor:
Janet Wittes, Salim Yusuf
Publikováno v:
New England Journal of Medicine. 375:2263-2271
In large multinational clinical therapeutic trials, responses in one region can differ from those in another. This article examines reasons for such differences and suggests criteria for determining whether the differences are real or the play of cha
Autor:
Irina Chazova, Leopoldo S. Piegas, Alexander Parkhomenko, Jackie Bosch, Patricio Lopez-Jaramillo, Hyejung Jung, Jun Zhu, Gilles R. Dagenais, Eva Lonn, Kamlesh Khunti, Karen Sliwa, Antonio L. Dans, Hope Investigators, Salim Yusuf, Petr Jansky, Basil S. Lewis, Matyas Keltai, John Varigos, Gregorio Sanchez-Vallejo, Ron J.G. Peters, Lisheng Liu, Denis Xavier, Janice Pogue, Robert S. McKelvie, Alvaro Avezum, Claes Held, William D. Toff, Katalin Keltai, Christopher M. Reid, Lawrence A. Leiter, Rafael Diaz, Prem Pais, Khalid Yusoff, Peggy Gao
Publikováno v:
Repositorio Universidad de Santander
Universidad de Santander
instacron:Universidad de Santander
New England journal of medicine, 374(21), 2021-2031. Massachussetts Medical Society
Universidad de Santander
instacron:Universidad de Santander
New England journal of medicine, 374(21), 2021-2031. Massachussetts Medical Society
11 p.
BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inf
BACKGROUND Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inf
Autor:
Joanne Wilkinson, Katalin Keltai, Prem Pais, William D. Toff, Christopher M. Reid, Irina Chazova, Leopoldo S. Piegas, John Varigos, Jackie Bosch, Alvaro Avezum, Rafael Diaz, Claes Held, Alexander Parkhomenko, Salim Yusuf, Jun Zhu, Lawrence A. Leiter, Lisheng Liu, Robert S. McKelvie, Eva Lonn, Petr Jansky, Antonio L. Dans, Karen Sliwa, Basil S. Lewis, Matyas Keltai, Janice Pogue, Khalid Yusoff, Kamlesh Khunti, Ron J.G. Peters, Denis Xavier, Patricio Lopez-Jaramillo, Dora I. Molina, Hyejung Jung, Gilles R. Dagenais
Publikováno v:
Repositorio Universidad de Santander
Universidad de Santander
instacron:Universidad de Santander
New England journal of medicine, 374(21), 2009-2020. Massachussetts Medical Society
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidad de Santander
instacron:Universidad de Santander
New England journal of medicine, 374(21), 2009-2020. Massachussetts Medical Society
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
12 p.
BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood
BACKGROUND Antihypertensive therapy reduces the risk of cardiovascular events among high-risk persons and among those with a systolic blood pressure of 160 mm Hg or higher, but its role in persons at intermediate risk and with lower blood
Autor:
Sanjit S. Jolly, John A. Cairns, Salim Yusuf, Brandi Meeks, Janice Pogue, Michael J. Rokoss, Sasko Kedev, Lehana Thabane, Goran Stankovic, Raul Moreno, Anthony Gershlick, Saqib Chowdhary, Shahar Lavi, Kari Niemelä, Philippe Gabriel Steg, Ivo Bernat, Yawei Xu, Warren J. Cantor, Christopher B. Overgaard, Christoph K. Naber, Asim N. Cheema, Robert C. Welsh, Olivier F. Bertrand, Alvaro Avezum, Ravinay Bhindi, Samir Pancholy, Sunil V. Rao, Madhu K. Natarajan, Jurriën M. ten Berg, Olga Shestakovska, Peggy Gao, Petr Widimsky, Vladimír Džavík
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
The primary outcome occurred in 347 of 5033 patients (6.9%) in the thrombectomy group versus 351 of 5030 patients (7.0%) in the PCI-alone group (hazard ratio in the thrombectomy group, 0.99; 95% confidence interval [CI], 0.85 to 1.15; P = 0.86). The